Clinical features of COVID-19 patients with non-alcoholic fatty liver disease.

Rui HuangLi ZhuJian WangLeyang XueLonggen LiuXuebing YanSongping HuangYang LiXiaomin YanBiao ZhangTianmin XuChunyang LiFang JiFang MingYun ZhaoJuan ChengYinling WangHaiyan ZhaoShuqin HongKang ChenXiang-An ZhaoLei ZouDawen SangHuaping ShaoXinying GuanXiaobing ChenYuxin ChenJie WeiChuanwu ZhuChao Wu

Published in: Hepatology communications (2020)

NAFLD patients are more likely to develop liver injury when infected by COVID-19. However, no patient developed severe liver-related complications during hospitalization.

Keyphrases

liver injury
drug induced
sars cov
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
risk factors
case report
patient reported outcomes